Prolight Diagnostics AB (publ)

NGM:PRLD Stock Report

Market Cap: SEK 92.7m

Prolight Diagnostics Past Earnings Performance

Past criteria checks 0/6

Prolight Diagnostics's earnings have been declining at an average annual rate of -74.2%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 60.8% per year.

Key information

-74.2%

Earnings growth rate

-54.6%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate60.8%
Return on equity-121.9%
Net Margin-479.7%
Next Earnings Update21 Feb 2025

Recent past performance updates

Recent updates

Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Jul 14
Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth

Nov 07
Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth

We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth

Jul 06
We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth

Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth

Mar 09
Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth

Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans

Nov 24
Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans

Revenue & Expenses Breakdown

How Prolight Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:PRLD Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2429-139540
30 Jun 2425-140510
31 Mar 2424-137470
31 Dec 2324-135460
30 Sep 2331-22530
30 Jun 2333-17500
31 Mar 2336-16520
31 Dec 2235-12480
30 Sep 2215-17330
30 Jun 229-14230
31 Mar 223-9120
31 Dec 210-770
30 Sep 210-770
30 Jun 211-660
31 Mar 211-450
31 Dec 201-450
30 Sep 201-440
30 Jun 200-340
31 Mar 200-540
31 Dec 190-440
30 Sep 190-540
30 Jun 190-650
31 Mar 190-650
31 Dec 180-650
30 Sep 181-550
30 Jun 180-440
31 Mar 180-330
31 Dec 170-330
30 Sep 170-440
30 Jun 170-330
31 Mar 170-330
31 Dec 160-220
31 Dec 150-220

Quality Earnings: PRLD is currently unprofitable.

Growing Profit Margin: PRLD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PRLD is unprofitable, and losses have increased over the past 5 years at a rate of 74.2% per year.

Accelerating Growth: Unable to compare PRLD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PRLD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: PRLD has a negative Return on Equity (-121.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:27
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Prolight Diagnostics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution